Company Overview of Edusa Pharmaceuticals, Inc.
Edusa Pharmaceuticals, Inc. produces a compound to treat gastroesophageal reflux disease. It develops Pumosetrag, a 5-HT3 partial agonist to treat the symptoms of upper gastrointestinal dismotility. The Pumosetrag is used to treat gastroesophageal reflux disease and potentially gastroparesis symptoms in patients who continue to experience heartburn and regurgitation while on proton pump inhibitors or H2-antagonists. Edusa Pharmaceuticals, Inc. was formerly known as Dynogen Pharmaceuticals, Inc. and changed its name to Edusa Pharmaceuticals, Inc. in June 2009. Edusa Pharmaceuticals, Inc. was founded in 2002 and is based in Princeton, New Jersey.
104 Carnegie Center
Princeton, NJ 08540
Founded in 2002
Key Executives for Edusa Pharmaceuticals, Inc.
Similar Private Companies By Industry
|Meda Pharmaceuticals Inc.||United States|
|Caliber Biotherapeutics, LLC||United States|
|L Perrigo Company Inc.||United States|
|Eurohealth (U.S.A.), Inc.||United States|
|Jennerex Biotherapeutics, Inc.||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
To contact Edusa Pharmaceuticals, Inc., please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.